We are live on ! Find out more
Bessemer Group

Bessemer Group Portfolio holdings

AUM $63.6B
1-Year Est. Return 28.76%
This Fund
S&P 500
This Quarter Est. Return
+9.59%
1 Year Est. Return
+28.76%
3 Year Est. Return
+103.2%
5 Year Est. Return
+139.19%
10 Year Est. Return
+508.5%
AUM
$14B
AUM Growth
+$1.63B
Cap. Flow
+$225M
Cap. Flow %
1.61%
Top 10 Hldgs %
16.45%
Holding
1,448
New
199
Increased
366
Reduced
275
Closed
98

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$98.9M
2
GE icon
GE Aerospace
GE
+$95.9M
3
MSFT icon
Microsoft
MSFT
+$92.5M
4
WBA
Walgreens Boots Alliance
WBA
+$67.4M
5
TPR icon
Tapestry
TPR
+$60.5M

Sector Composition

Rank Sector Weight
1 Healthcare 15.01%
2 Technology 14.16%
3 Financials 12.66%
4 Industrials 9.8%
5 Energy 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIR
326
DELISTED
SELECT INCOME REIT
SIR
$1.85M 0.01%
157,430
J icon
327
Jacobs Solutions
J
$15.9B
$1.84M 0.01%
35,283
-241
-0.7% -$11.9K
HD icon
328
Home Depot
HD
$332B
$1.8M 0.01%
21,893
+604
+3% +$47.1K
VZ icon
329
Verizon
VZ
$194B
$1.79M 0.01%
36,533
+20,351
+126% +$1M
ACP
330
abrdn Income Credit Strategies Fund
ACP
$640M
$1.78M 0.01%
+104,558
New +$1.72M
FAST icon
331
Fastenal
FAST
$54B
$1.75M 0.01%
147,496
-1,040
-0.7% -$12.5K
SKT icon
332
Tanger
SKT
$4.82B
$1.75M 0.01%
54,656
+25,208
+86% +$840K
UNH icon
333
UnitedHealth
UNH
$382B
$1.74M 0.01%
23,085
-2,488
-10% -$179K
IHS
334
DELISTED
IHS INC CL-A COM STK
IHS
$1.73M 0.01%
14,467
-317
-2% -$35.9K
DK icon
335
Delek US
DK
$3.87B
$1.73M 0.01%
50,161
VWO icon
336
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$1.72M 0.01%
41,890
-678
-2% -$28K
VOO icon
337
Vanguard S&P 500 ETF
VOO
$968B
$1.72M 0.01%
10,175
DE icon
338
Deere & Co
DE
$170B
$1.69M 0.01%
18,489
+13,188
+249% +$1.12M
GSK icon
339
GSK
GSK
$103B
$1.68M 0.01%
25,167
+311
+1% +$20.2K
NUE icon
340
Nucor
NUE
$56.4B
$1.68M 0.01%
31,461
+7,015
+29% +$362K
CBRE icon
341
CBRE Group
CBRE
$40.8B
$1.67M 0.01%
63,280
+23,817
+60% +$567K
COST icon
342
Costco
COST
$415B
$1.64M 0.01%
13,807
+34
+0.2% +$4.07K
APH icon
343
Amphenol
APH
$188B
$1.64M 0.01%
147,368
-5,160
-3% -$53.3K
MCRS
344
DELISTED
MICROS SYSTEMS INC
MCRS
$1.64M 0.01%
28,586
-935
-3% -$49.8K
SRE icon
345
Sempra
SRE
$60.8B
$1.62M 0.01%
36,134
+11,116
+44% +$494K
TDG icon
346
TransDigm Group
TDG
$69.2B
$1.58M 0.01%
9,830
-352
-3% -$52.5K
TWX
347
DELISTED
Time Warner Inc
TWX
$1.55M 0.01%
23,235
-536
-2% -$34.6K
MZTI
348
The Marzetti Company
MZTI
$2.94B
$1.55M 0.01%
17,600
MMP
349
DELISTED
Magellan Midstream Partners, L.P.
MMP
$1.55M 0.01%
24,433
NVO
350
Novo Nordisk
NVO
$216B
$1.49M 0.01%
80,420
+21,070
+36% +$367K

Similar funds

Bessemer Group's Q4 2013 Portfolio in Review

As of Q4 2013, Bessemer Group held 1,448 positions worth $14B, up 13% from $12.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Bessemer Group's Q4 2013 filing shows 199 new, 366 increased, 275 reduced and 98 closed positions. Its largest new stake was iPath Pure Beta Broad Commodity ETN: 1,927,069 shares worth $76.1M. The largest sale was Teva Pharmaceuticals, an estimated $98.9M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

  • Bessemer Group's largest Q4 2013 buy was iPath Pure Beta Broad Commodity ETN: 1,927,069 shares worth $76.1M.
  • Bessemer Group added most to Viatris in Q4 2013, an estimated $154M increase.
  • Bessemer Group's biggest Q4 2013 reduction was Teva Pharmaceuticals, cutting an estimated $98.9M.
  • Bessemer Group fully exited Rayonier in Q4 2013, selling an estimated $33.4M.
  • Bessemer Group's ten largest holdings make up 16% of its $14B portfolio in Q4 2013.
  • Bessemer Group opened 199 new positions and closed 98 in Q4 2013.
  • Bessemer Group's portfolio value rose 13% quarter-over-quarter to $14B.

Based on Bessemer Group's 13F filing for Q4 2013, filed 18 Feb 2014.